Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration. | Life (Basel) | 2023 | 37240761 | PubTator, text mining | PubMed |
| Augmenting the Angiogenic Profile and Functionality of Cord Blood Endothelial Colony-Forming Cells by Indirect Priming with Bone-Marrow-Derived Mesenchymal Stromal Cells. | Biomedicines | 2023 | 37239042 | PubTator, text mining | PubMed |
| RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer. | Biomedicines | 2023 | 37238938 | PubTator, text mining | PubMed |
| Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges. | Mar Drugs | 2023 | 37233460 | PubTator, text mining | PubMed |
| Understanding and targeting resistance mechanisms in cancer. | MedComm (2020) | 2023 | 37229486 | PubTator, text mining | PubMed |
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC). | BMC Cancer | 2023 | 37217885 | PubTator, text mining | PubMed |
| Gut dysmotility in children with neurological impairment: the nutritional management. | Front Neurol | 2023 | 37213895 | PubTator, text mining | PubMed |
| Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma. | Front Oncol | 2023 | 37213288 | PubTator, text mining | PubMed |
| Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS). | J Cancer Res Clin Oncol | 2023 | 37213030 | PubTator, text mining | PubMed |
| The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis. | Cell Mol Immunol | 2023 | 37208442 | PubTator, text mining | PubMed |
| Integrating metabolomics and network pharmacology to assess the effects of quercetin on lung inflammatory injury induced by human respiratory syncytial virus. | Sci Rep | 2023 | 37198253 | PubTator, text mining | PubMed |
| Mitochondria and the eye-manifestations of mitochondrial diseases and their management. | Eye (Lond) | 2023 | 37185957 | PubTator, text mining | PubMed |
| Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children. | Hepatol Commun | 2023 | 37184518 | PubTator, text mining | PubMed |
| The Role of Angiogenesis Targeted Therapies in Metastatic Advanced Gastric Cancer: A Narrative Review. | J Clin Med | 2023 | 37176668 | PubTator, text mining | PubMed |
| NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins. | Cells | 2023 | 37174719 | PubTator, text mining | PubMed |
| A Novel Mutation in an MNGIE Patient Presenting with More Prominent Neurological Symptoms than GI Symptoms. | Neurol India | 2023 | 37148061 | PubTator, text mining | PubMed |
| Diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes: A case report. | Medicine (Baltimore) | 2023 | 37144988 | PubTator, text mining | PubMed |
| Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies. | Front Cell Dev Biol | 2023 | 37143892 | PubTator, text mining | PubMed |
| Tissue proteome analysis for profiling proteins associated with lymph node metastasis in gallbladder cancer. | BMC Cancer | 2023 | 37142981 | PubTator, text mining | PubMed |
| A neuron-specific Isca1 knockout rat developments multiple mitochondrial dysfunction syndromes. | Animal Model Exp Med | 2023 | 37140997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=15